RemeOs™
-
Extremities
The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with…
Read More » -
Spine
Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
TAMPERE, Finland, Oct. 4, 2024 /PRNewswire/ — Bioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody…
Read More » -
Financial
Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s half-year report January-June 2024. The complete half-year report…
Read More » -
Extremities
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures
TAMPERE, Finland, June 19, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of…
Read More » -
Spine
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage
TAMPERE, Finland, March 14, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation…
Read More » -
Extremities
Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws
TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution…
Read More » -
Spine
Bioretec unveils its revitalized Scientific Advisory Board (SAB), focusing on driving innovations in orthopedic implants
TAMPERE, Finland, Aug. 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing orthopedic biodegradable implants, has refined and expanded…
Read More » -
Extremities
Bioretec Ltd invests in a CNC machining center to increase the RemeOs™ production capacity
TAMPERE, Finland, June 13, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center…
Read More » -
Regulatory
Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product
TAMPERE, Finland, March 30, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic implants, has today announced receiving the market authorization of…
Read More » -
Regulatory
Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw
TAMPERE, Finland, Nov. 4, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs™…
Read More » -
Extremities
Bioretec updates estimate of U.S. registration of RemeOs™ screws and expects approval in April 2023
TAMPERE, Finland, Oct. 14, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, continues to discuss the company’s RemeOs™ trauma…
Read More » -
Regulatory
Bioretec files for CE mark for its bioresorbable RemeOs magnesium screw in the EU
HELSINKI, Dec. 31, 2021 /PRNewswire/ — Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has submitted an application for the CE mark…
Read More »